Beacon Pointe Advisors, LLC Novo Nordisk A S Transaction History

Beacon Pointe Advisors, LLC

  • $8.55 Billion
  • Q3 2024

A detailed history of Beacon Pointe Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 45,360 shares of NVO stock, worth $4.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
45,360
Previous 49,213 7.83%
Holding current value
$4.9 Million
Previous $7.02 Million 23.11%
% of portfolio
0.06%
Previous 0.08%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.07 - $145.42 $458,776 - $560,303
-3,853 Reduced 7.83%
45,360 $5.4 Million
Q2 2024

Aug 12, 2024
SELL
$122.71 - $146.91 $388,009 - $464,529
-3,162 Reduced 6.04%
49,213 $7.02 Million
Q1 2024

May 14, 2024
BUY
$102.11 - $135.92 $122,634 - $163,239
1,201 Added 2.35%
52,375 $6.72 Million
Q4 2023

Feb 08, 2024
SELL
$87.78 - $105.45 $5.92 Million - $7.11 Million
-67,425 Reduced 56.85%
51,174 $5.29 Million
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $9.79 Million - $21.5 Million
107,708 Added 988.96%
118,599 $10.8 Million
Q2 2023

Aug 11, 2023
SELL
$155.98 - $172.65 $72,842 - $80,627
-467 Reduced 4.11%
10,891 $1.76 Million
Q1 2023

May 12, 2023
SELL
$132.34 - $159.14 $31,496 - $37,875
-238 Reduced 2.05%
11,358 $1.81 Million
Q4 2022

Feb 14, 2023
BUY
$102.55 - $135.33 $279,858 - $369,315
2,729 Added 30.78%
11,596 $1.57 Million
Q3 2022

Nov 09, 2022
SELL
$95.28 - $116.93 $9,146 - $11,225
-96 Reduced 1.07%
8,867 $883,000
Q2 2022

Aug 11, 2022
SELL
$103.24 - $121.81 $4.33 Million - $5.11 Million
-41,963 Reduced 82.4%
8,963 $999,000
Q1 2022

May 17, 2022
BUY
$93.1 - $112.54 $3.57 Million - $4.32 Million
38,381 Added 305.95%
50,926 $5.66 Million
Q4 2021

Feb 14, 2022
BUY
$95.88 - $117.08 $513,820 - $627,431
5,359 Added 74.58%
12,545 $1.41 Million
Q3 2021

Nov 15, 2021
SELL
$84.42 - $106.62 $360,642 - $455,480
-4,272 Reduced 37.28%
7,186 $690,000
Q2 2021

Aug 17, 2021
BUY
$67.66 - $84.76 $389,450 - $487,878
5,756 Added 100.95%
11,458 $960,000
Q1 2021

May 18, 2021
BUY
$67.06 - $75.82 $171,204 - $193,568
2,553 Added 81.07%
5,702 $384,000
Q4 2020

Feb 12, 2021
BUY
$63.89 - $73.8 $201,189 - $232,396
3,149 New
3,149 $219,000
Q2 2019

Aug 14, 2019
SELL
$46.79 - $52.47 $3.56 Million - $4 Million
-76,147 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$46.36 - $52.63 $3.53 Million - $4.01 Million
76,147 New
76,147 $3.98 Million

Others Institutions Holding NVO

# of Institutions
1,956
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email